Mutations or variants of several co-targets serve as markers of human DCM and/or other cardiomyopathies such as desmoplakin (Dsp), filamin C (Flnc), myomesin 1 (Myom1), striated muscle enriched protein kinase (Speg), troponin I, cardiac muscle (Tnni3), and titin (Ttn)66–68. This evidence concerns the gene DSP and cardiomyopathy.